Skip to main content

Grafa News and Videos — Page 1118

Grafa Headlines

Latest

Grafa

J&J’s experimental Sjögren's treatment shows greater impact in key patient subgroup

Johnson & Johnson (NYSE:JNJ) disclosed new data on Wednesday showing its experimental autoimmune treatment, nipocalimab, yields stronger clinical results in patients with higher concentrations of specific disease-driving biomarkers.

Read more: J&J’s experimental Sjögren's treatment shows greater impact in key patient subgroup
Grafa

argenx showcases long-term Vyvgart data in Myositis and Sjogren’s disease

argenx (NASDAQ:ARGX) reported new clinical data for its neonatal Fc receptor (FcRn) blocker, Vyvgart (efgartigimod), demonstrating durable therapeutic benefits and a highly consistent safety profile for patients living with myositis and Sjogren’s disease.

Read more: argenx showcases long-term Vyvgart data in Myositis and Sjogren’s disease
Grafa
Media

Meta wins court battle over marketplace 'gatekeeper' tag, Messenger challenge fails

Meta Platforms (NASDAQ:META) scored a partial victory in its legal battle against sweeping European Union digital regulations on Wednesday, as Europe's second-highest court overturned an antitrust label applied to its Marketplace platform while upholding the same restrictions for its Messenger app.

Read more: Meta wins court battle over marketplace 'gatekeeper' tag, Messenger challenge fails

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift